ForecastRFI

AJ13--Pharmarcokinetics for Experimental Rheumatoid Arthritis treatment

VETERANS AFFAIRS, DEPARTMENT OFVETERANS AFFAIRS, DEPARTMENT OF.VETERANS AFFAIRS, DEPARTMENT OF.245-NETWORK CONTRACT OFFICE 5 (36C245)

AI Overview

GLP-compliant preclinical toxicology and pharmacokinetic studies for peptide-displaying liposomal dexamethasone delivery system targeting rheumatoid arthritis, supporting FDA Pre-IND advancement.

This summary is AI-generated from the official solicitation.

Key Details

Agency
VETERANS AFFAIRS, DEPARTMENT OF
Funding Amount
Release Date
July 16, 2026
Due Date
July 31, 2026

Official Description

SOURCES SOUGHT NOTICE Department of Veterans Affairs Network Contracting Office (NCO) 05 Title: A Joint Targeted Drug Delivery Approach for Arthritis Therapy Toxicity and Pharmacokinetics

  1. Purpose This Sources Sought Notice is issued solely for market research in accordance with FAR Part 10. This is not a solicitation, and it does not commit the Government to issue a solicitation or make an award. The Department of Veterans Affairs (VA) seeks to identify qualified vendors capable of performi...
View on official source

Change History

Opportunity AddedJul 16, 2026 at 1:03 PM

AJ13--Pharmarcokinetics for Experimental Rheumatoid Arthritis treatment

New SAM.gov opportunity: AJ13--Pharmarcokinetics for Experimental Rheumatoid Arthritis treatment

Similar Opportunities

Get Alerts for Opportunities Like This

RallyProp monitors thousands of funding sources and sends instant alerts when opportunities match your technology and capabilities.

Start Free Trial